Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.
Restylane Contour, a hyaluronic acid injectable dermal filler, has received FDA approval for the “correction of temple ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results